Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Twist Bioscience (TWST)
:TWST
Holding TWST?
Track your performance easily
TWST Stock Chart & Stats
Day’s Range― - ―
52-Week Range$27.41 - $60.90
Previous CloseN/A
Volume152.02K
Average Volume (3M)758.98K
Market Cap
$2.73B
Enterprise Value$2.45B
Total Cash (Recent Filing)$62.20M
Total Debt (Recent Filing)$9.15M
Price to Earnings (P/E)―
Beta3.72
Next Earnings
Jan 31, 2025EPS Estimate
-0.63Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.60
Shares Outstanding59,582,233
10 Day Avg. Volume691,257
30 Day Avg. Volume758,976
Standard Deviation0.21
R-Squared0.21
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)9.22
Price to Cash Flow (P/CF)-44.40
P/FCF Ratio0.00
Enterprise Value/Market Cap0.90
Enterprise Value/Revenue8.06
Enterprise Value/Gross Profit18.40
Enterprise Value/Ebitda-13.80
Forecast
1Y Price Target
$50.71Price Target Upside6.62% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Twist Bioscience News
PremiumCompany Announcements
Twist Bioscience Reports Record Revenue in 2024
Bulls Say, Bears Say
Bulls Say
Growth PotentialTwist Bioscience is projected to have a growth rate double that of its peers, demonstrating strong potential for future expansion.
Market LeadershipTwist Bioscience is recognized as a leading enabler of synthetic biology due to its unique, low-cost DNA synthesis platform that enhances demand flexibility.
Operational EfficiencyFundamental improvements to margins include new software distribution and automation, which doubles distribution capacity and saves on materials.
Bears Say
Market OutlookThe outlook for the sector is likely to weigh on the shares in the near-medium term until R&D growth across pharma is more clear.
Regulatory EnvironmentThe guide implies significant deceleration, which is viewed as prudent in a changing regulatory environment.
Revenue DeclineBiopharma remains small at 6% of TWST's revenue and is on track to decline more than 10% in FY24.
---
Ownership Overview
3.17% Insiders
28.32% Mutual Funds
0.08% Other Institutional Investors
41.29% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TWST FAQ
What was Twist Bioscience’s price range in the past 12 months?
Twist Bioscience lowest stock price was $27.41 and its highest was $60.90 in the past 12 months.
What is Twist Bioscience’s market cap?
Twist Bioscience’s market cap is $2.73B.
When is Twist Bioscience’s upcoming earnings report date?
Twist Bioscience’s upcoming earnings report date is Jan 31, 2025 which is in 10 days.
How were Twist Bioscience’s earnings last quarter?
Twist Bioscience released its earnings results on Nov 18, 2024. The company reported -$0.59 earnings per share for the quarter, beating the consensus estimate of -$0.714 by $0.124.
Is Twist Bioscience overvalued?
According to Wall Street analysts Twist Bioscience’s price is currently Undervalued.
Does Twist Bioscience pay dividends?
Twist Bioscience does not currently pay dividends.
What is Twist Bioscience’s EPS estimate?
Twist Bioscience’s EPS estimate is -0.63.
How many shares outstanding does Twist Bioscience have?
Twist Bioscience has 59,582,233 shares outstanding.
What happened to Twist Bioscience’s price movement after its last earnings report?
Twist Bioscience reported an EPS of -$0.59 in its last earnings report, beating expectations of -$0.714. Following the earnings report the stock price went up 12.307%.
Which hedge fund is a major shareholder of Twist Bioscience?
Currently, no hedge funds are holding shares in TWST
---
Twist Bioscience Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$50.71 (6.62% Upside)
$50.71 (6.62% Upside)
Blogger Sentiment
Bullish
TWST Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 1.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 0.8%
Last 30 Days ▲ 3.0%
Last 30 Days ▲ 3.0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
36.50%
12-Months-Change
Fundamentals
Return on Equity
-38.08%
Trailing 12-Months
Asset Growth
-20.88%
Trailing 12-Months
Company Description
Twist Bioscience
Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The company also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. Twist Bioscience was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013 and is headquartered in San Francisco, CA.
---
TWST Company Deck
---
TWST Earnings Call
Q4 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
Twist Bioscience reported strong financial results with record-breaking revenues and significant gross margin improvements, driven by operational efficiencies and robust NGS performance. However, challenges in the biopharma segment and limited market impact in China were noted. Overall, the positive highlights significantly outweigh the lowlights.Read More>---
TWST Stock 12 Month Forecast
Average Price Target
$50.71
▲(6.62% Upside)
Technical Analysis
Crispr Therapeutics AG
―
Intellia Therapeutics
―
Editas Medicine
―
Beam Therapeutics
―
Sangamo Biosciences
―
Veracyte
―
Best Analysts Covering TWST
1 Year
1 Year Success Rate
15/29 ratings generated profit
1 Year Average Return
+18.14%
reiterated a buy rating 2 months ago
Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 51.72% of your transactions generating a profit, with an average return of +18.14% per trade.
---